Clinical Trials Directory

Trials / Unknown

UnknownNCT03456570

The Efficacy of Progestins in Treatment of Functional Ovarian Cyst

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to determine whether the use of progesterone only pills has a beneficial effect over the expectant management of functional ovarian cyst or not , through a sample of female patients within the reproductive years

Detailed description

An ovarian cyst is a common gynecological problem and is divided into 2 main categories; physiological and pathological In relative frequency, functional cysts account for about 24% of all ovarian cysts, benign cysts 70% and malignant 6% Functional cysts are the most common masses seen in the premenopausal ovary and are estimated to affect 8%-20% of reproductive-aged women Pain or discomfort in the lower abdomen Severe pain from torsion (twisting) or rupture - Cyst rupture is characterized by sudden, sharp, unilateral pelvic pain; this can be associated with trauma, exercise, or coitus. Cyst rupture can lead to peritoneal signs, abdominal distention, and bleeding (which is usually self-limited) Discomfort with intercourse, particularly deep penetration Changes in bowel movements such as constipation Pelvic pressure causing tenesmus or urinary frequency Menstrual irregularities Precocious puberty and early menarche in young children Abdominal fullness and bloating Indigestion, heartburn, or early satiety Hyperpyrexia - This may result from some complications of ovarian cysts, such as ovarian torsion Adnexal or cervical motion tenderness In current clinical practice , gynecologists treat functional ovarian cysts with either oral Contraceptive pills or expectant management alone. we presume using progesterone only pills for treatment of functional ovarian cyst

Conditions

Interventions

TypeNameDescription
DRUGDydrogesterone 10 mgDydrogesterone 10 mg twice daily
DRUGPlacebo Oral Tabletoral tablets twice daily

Timeline

Start date
2018-05-01
Primary completion
2020-05-01
Completion
2020-09-01
First posted
2018-03-07
Last updated
2018-03-07

Source: ClinicalTrials.gov record NCT03456570. Inclusion in this directory is not an endorsement.